Bray Capital Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Bray Capital Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-460	Closed	-$18K	–	270
2020 Q1	$18K	Hold	460	–	–	0.01%	213
2019 Q4	$21K	Hold	460	–	–	0.01%	221
2019 Q3	$19K	Hold	460	–	–	0.01%	227
2019 Q2	$22K	Hold	460	–	–	0.01%	233
2019 Q1	$29K	Hold	460	–	–	0.01%	218
2018 Q4	$27K	Hold	460	–	–	0.01%	220
2018 Q3	$30K	Sell	460 -330	-42%	-$18.4K	0.01%	221
2018 Q2	$36K	Sell	790 -140	-15%	-$5.58K	0.02%	238
2018 Q1	$29K	Buy	+930	New	+$30.6K	0.01%	248

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bray Capital Advisors's BEAT Position: Q2 2020 in Review

Bray Capital Advisors sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 460 shares — an estimated $18K sold.

Bray Capital Advisors first reported a position in BEAT in Q1 2018 and held it in 9 quarters. The position peaked at $36K in Q2 2018. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

Bray Capital Advisors reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
Bray Capital Advisors sold 460 BioTelemetry, Inc. shares in Q2 2020, an estimated $18K.
Bray Capital Advisors first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 9 quarters.
Bray Capital Advisors's BioTelemetry, Inc. position peaked at $36K in Q2 2018.
215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Bray Capital Advisors's 13F filing for Q2 2020, filed 28 Jul 2020.